Gout
Dr. Sunil pahari
3rd Year Resident
Department of Orthopedic surgery, Yangtze University
jingzhou , hubei , P.R. China
Definition
• Acute inflammatory monoarthritis
caused by precipitation of monosodium
urate (MSU) crystals in joints
• Uric acid is the normal end product of
the degradation of purine compounds.
– Major route of disposal is renal excretion
– Humans lack the enzyme uricase to break
down uric acid into more soluble form.
Epidemiology
• Most common of microcrystalline arthropathy
• Affects about 2.1million worldwide
• Gout is 5 times more common in males
• Acute attack tend to occur after a large meal or
alcohol consumption ( alcohol metabolites
compete for same excretion sites in kidney as
uric acid, causing decrease uric acid secretion
and subsequent build up in blood )
Classification of Hyperuricemia
• Uric acid overproduction
– Accounts for 10% of hyperuricemia
– Acquired disorders
• Excessive cell turnover rates such as myleoproliferative
disorders, Paget’s disease, hemolytic anemias
• Uric acid underexcretion
– Accounts for >90% of hyperuricemia
– Diminished tubular secretory rate, increased tubular
reabsorption, diminished uric acid filtration
– Can be exacerbated by certain medication ( thiazide diuretics)
Stages of Classic Gout
• Asymptomatic hyperuricemia
– Very common biochemical abnormality
– Majority of people with hyperuricemia never develop symptoms of uric acid
excess
• Acute Intermittent Gout (Gouty Arthritis)
– Episodes of acute attacks. Symptoms may be confined to a single joint or patient
may have systemic symptoms.
• Intercritical Gout
– Symptom free period interval between attacks. May have hyperuricemia and
MSU crystals in synovial fluid
• Chronic Tophaceous Gout
– Results from established disease and refers to stage of deposition of urate,
inflammatory cells and foreign body giant cells in the tissues. Deposits may be in
tendons or ligaments.
– Usually develops after 10 or more years of acute intermittent gout.
Presenting Symptoms
• Systemic: may have fever,
chills and malaise
• Musculoskeletal:
• Asymmetric joint distribution
• Joint is swollen ,red and painful.
• Classic manifestation is painful
MTP joint of the big toe
(podagra)
Tophus formation (often on
external ear,olecranon bursa ,
Achilles tendon )
Tophi achilles
Differential Diagnosis
• Trauma
• Infections
– septic arthritis, gonococcal arthritis, cellulitis
• Inflammatory
– Rheumatic arthritis, Reiter’s syndrome, Psoriatic
arthritis
• Metabolic
– pseudogout ( calcium pyrophosphate crystal )
• Miscellaneous
– Osteoarthrtis
Diagnosis
• Definitive diagnosis
only possible by
aspirating and
inspecting synovial
fluid or tophaceous
material and
demonstrating MSU
crystals.
• yellow crystals
Synovial Fluid Findings
• Needle shaped
crystals of
monosodium urate
monohydrate that
have been engulfed
by neutrophils
Diagnostic Studies
• Uric Acid
– Rise
• CBC
– Mild leukocytosis in acute attacks, but may be higher than 25,000/mm
• ESR
– mild elevation or may be 2-3x normal
• 24hr urine uric acid
– Only useful in patients being considered for uricosuric therapy or if
cause of marked hyperuricemia needs investigation .
Treatment Goals
• Gout can be treated without
complications.
• Therapeutic goals include
– terminating attacks
– providing control of pain and inflammation
– preventing future attacks
– preventing complications such as renal
stones, tophi, and destructive arthropathy
Treatment mechanism
Acute Gout Treatment
• NSAIDs
– Most commonly used.
– No NSAID found to work better than others
– Regimens:
• Indocin 50mg po bid-tid for 2-3 days and then taper
• Ibuprofen 400mg po q4-6 hr max 3.2g/day
• Ketorolac 60mg IM or 30mg IV X1 dose in patients<65
– 30mg IM or 15mg IV in single dose in patients >65yo, or with
patients who are renally impaired
• Continue meds until pain and inflammation have resolved for
48hr
Acute Treatment
• Colchicine
– Inhibits microtubule aggregation which disrupts
chemotaxis and phagocytosis
– Inhibts crystal-induced production of chemotatic
factors
– Administered orally in hourly doses of 0.5 to 0.6mg
until pain and inflammation have resolved or until GI
side effects prevent further use. Max dose 6mg/24hr
– 2mg IV then 0.5mg q6 until cumulative dose of 4mg
over 24hr
Acute treatment cont’d
• Corticosteriods
– Patients who cannot tolerate NSAIDs, or failed NSAID/colchicine
therapy
– Daily doses of prednisone 40-60mg a day for 3-5 days then
taper 1-2 weeks
– Improvement seen in 12-24hr
• Intra-articular injection with steroids
– Beneficial in patient with one or two large joints affected
– Good option for elderly patient with renal or PUD or other illness
– Triamcinolone 10-40mg or Dexamethasone 2-10mg alone or in
combination with Lidocaine
Chronic gout drugs (preventive)
• Allopurinol- MoA – inhibit xanthine
oxidase, decrease conversion of xanthine
to uric acid .
• Febuxostat- inhibit xanthine oxidase
• Probenecid (uricosuric drug )- inhibit
reabsortion of uric acid in PCT.
Non- Pharmacologic Treatments
• Immobilization of Joint
• Ice Packs
• Abstinence of Alcohol
– Consumption can increase serum urate levels by
increasing uric acid . When used in excess it can be
converted to lactic acid which inhibits uric acid
excretion in the kidney
• Dietary modification
– Low carbohydrates
– Decrease in dietary purine-meat and seafood
– Dairy and vegetables do not seem to affect uric acid
Newer Therapies
• Uricase
– Enzyme that oxidizes uric acid to a more soluble form
– Natural Uricase from Aspergillus flavus and Candida utilis under
investigation
• Febuxostat
– New class of Xanthine Oxidase inhibitor
– More selective than allopurinol
– Little dependence on renal excretion
• Losartan
• Fenofibrate
Complications
• Renal Failure
– ARF can be caused by
hyperuricemia, chronic
urate nephropathy
• Nephrolithiasis
• Joint deformity
• Recurrent Gout
Pseudo gout

Gout

  • 1.
    Gout Dr. Sunil pahari 3rdYear Resident Department of Orthopedic surgery, Yangtze University jingzhou , hubei , P.R. China
  • 2.
    Definition • Acute inflammatorymonoarthritis caused by precipitation of monosodium urate (MSU) crystals in joints • Uric acid is the normal end product of the degradation of purine compounds. – Major route of disposal is renal excretion – Humans lack the enzyme uricase to break down uric acid into more soluble form.
  • 3.
    Epidemiology • Most commonof microcrystalline arthropathy • Affects about 2.1million worldwide • Gout is 5 times more common in males • Acute attack tend to occur after a large meal or alcohol consumption ( alcohol metabolites compete for same excretion sites in kidney as uric acid, causing decrease uric acid secretion and subsequent build up in blood )
  • 4.
    Classification of Hyperuricemia •Uric acid overproduction – Accounts for 10% of hyperuricemia – Acquired disorders • Excessive cell turnover rates such as myleoproliferative disorders, Paget’s disease, hemolytic anemias • Uric acid underexcretion – Accounts for >90% of hyperuricemia – Diminished tubular secretory rate, increased tubular reabsorption, diminished uric acid filtration – Can be exacerbated by certain medication ( thiazide diuretics)
  • 5.
    Stages of ClassicGout • Asymptomatic hyperuricemia – Very common biochemical abnormality – Majority of people with hyperuricemia never develop symptoms of uric acid excess • Acute Intermittent Gout (Gouty Arthritis) – Episodes of acute attacks. Symptoms may be confined to a single joint or patient may have systemic symptoms. • Intercritical Gout – Symptom free period interval between attacks. May have hyperuricemia and MSU crystals in synovial fluid • Chronic Tophaceous Gout – Results from established disease and refers to stage of deposition of urate, inflammatory cells and foreign body giant cells in the tissues. Deposits may be in tendons or ligaments. – Usually develops after 10 or more years of acute intermittent gout.
  • 8.
    Presenting Symptoms • Systemic:may have fever, chills and malaise • Musculoskeletal: • Asymmetric joint distribution • Joint is swollen ,red and painful. • Classic manifestation is painful MTP joint of the big toe (podagra) Tophus formation (often on external ear,olecranon bursa , Achilles tendon ) Tophi achilles
  • 9.
    Differential Diagnosis • Trauma •Infections – septic arthritis, gonococcal arthritis, cellulitis • Inflammatory – Rheumatic arthritis, Reiter’s syndrome, Psoriatic arthritis • Metabolic – pseudogout ( calcium pyrophosphate crystal ) • Miscellaneous – Osteoarthrtis
  • 10.
    Diagnosis • Definitive diagnosis onlypossible by aspirating and inspecting synovial fluid or tophaceous material and demonstrating MSU crystals. • yellow crystals
  • 11.
    Synovial Fluid Findings •Needle shaped crystals of monosodium urate monohydrate that have been engulfed by neutrophils
  • 12.
    Diagnostic Studies • UricAcid – Rise • CBC – Mild leukocytosis in acute attacks, but may be higher than 25,000/mm • ESR – mild elevation or may be 2-3x normal • 24hr urine uric acid – Only useful in patients being considered for uricosuric therapy or if cause of marked hyperuricemia needs investigation .
  • 13.
    Treatment Goals • Goutcan be treated without complications. • Therapeutic goals include – terminating attacks – providing control of pain and inflammation – preventing future attacks – preventing complications such as renal stones, tophi, and destructive arthropathy
  • 14.
  • 15.
    Acute Gout Treatment •NSAIDs – Most commonly used. – No NSAID found to work better than others – Regimens: • Indocin 50mg po bid-tid for 2-3 days and then taper • Ibuprofen 400mg po q4-6 hr max 3.2g/day • Ketorolac 60mg IM or 30mg IV X1 dose in patients<65 – 30mg IM or 15mg IV in single dose in patients >65yo, or with patients who are renally impaired • Continue meds until pain and inflammation have resolved for 48hr
  • 16.
    Acute Treatment • Colchicine –Inhibits microtubule aggregation which disrupts chemotaxis and phagocytosis – Inhibts crystal-induced production of chemotatic factors – Administered orally in hourly doses of 0.5 to 0.6mg until pain and inflammation have resolved or until GI side effects prevent further use. Max dose 6mg/24hr – 2mg IV then 0.5mg q6 until cumulative dose of 4mg over 24hr
  • 17.
    Acute treatment cont’d •Corticosteriods – Patients who cannot tolerate NSAIDs, or failed NSAID/colchicine therapy – Daily doses of prednisone 40-60mg a day for 3-5 days then taper 1-2 weeks – Improvement seen in 12-24hr • Intra-articular injection with steroids – Beneficial in patient with one or two large joints affected – Good option for elderly patient with renal or PUD or other illness – Triamcinolone 10-40mg or Dexamethasone 2-10mg alone or in combination with Lidocaine
  • 18.
    Chronic gout drugs(preventive) • Allopurinol- MoA – inhibit xanthine oxidase, decrease conversion of xanthine to uric acid . • Febuxostat- inhibit xanthine oxidase • Probenecid (uricosuric drug )- inhibit reabsortion of uric acid in PCT.
  • 19.
    Non- Pharmacologic Treatments •Immobilization of Joint • Ice Packs • Abstinence of Alcohol – Consumption can increase serum urate levels by increasing uric acid . When used in excess it can be converted to lactic acid which inhibits uric acid excretion in the kidney • Dietary modification – Low carbohydrates – Decrease in dietary purine-meat and seafood – Dairy and vegetables do not seem to affect uric acid
  • 20.
    Newer Therapies • Uricase –Enzyme that oxidizes uric acid to a more soluble form – Natural Uricase from Aspergillus flavus and Candida utilis under investigation • Febuxostat – New class of Xanthine Oxidase inhibitor – More selective than allopurinol – Little dependence on renal excretion • Losartan • Fenofibrate
  • 21.
    Complications • Renal Failure –ARF can be caused by hyperuricemia, chronic urate nephropathy • Nephrolithiasis • Joint deformity • Recurrent Gout
  • 22.